US Stock MarketDetailed Quotes

TNGX Tango Therapeutics

Watchlist
  • 3.630
  • -0.450-11.03%
Close Nov 21 16:00 ET
389.93MMarket Cap-3156P/E (TTM)

Tango Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-7.24%-33.39M
3.54%-23.61M
-8.45%-37.86M
-8.16%-117.98M
2.83%-27.47M
-58.76%-31.14M
22.40%-24.47M
-17.67%-34.91M
-83.24%-109.08M
-67.23%-28.27M
Net income from continuing operations
-31.01%-29.17M
-23.38%-25.55M
-35.37%-37.91M
5.95%-101.74M
-5.86%-30.76M
23.36%-22.26M
16.69%-20.71M
-11.11%-28.01M
-85.76%-108.18M
-31.82%-29.06M
Depreciation and amortization
1.47%622K
4.64%632K
7.57%625K
50.19%2.42M
8.25%617K
47.00%613K
93.59%604K
88.03%581K
79.26%1.61M
122.66%570K
Other non cash items
0.86%941K
7.56%968K
3.86%915K
107.20%3.63M
361.62%914K
14.90%933K
176.07%900K
112.29%881K
32.35%1.75M
-50.99%198K
Change In working capital
26.47%-11.78M
37.03%-5.99M
41.55%-6.83M
-105.30%-37.97M
81.15%-750K
-446.46%-16.02M
11.53%-9.51M
-39.36%-11.69M
-63.01%-18.49M
-278.63%-3.98M
-Change in receivables
--0
--0
--0
--2M
--0
--0
--0
--2M
--0
--0
-Change in prepaid assets
-10.63%-1.24M
566.04%2.14M
112.94%360K
-8.22%-2.23M
279.26%1.36M
-109.87%-1.12M
103.58%321K
24.52%-2.78M
34.92%-2.06M
-1,301.59%-757K
-Change in payables and accrued expense
134.22%1.28M
-79.61%254K
88.99%-567K
-142.79%-3.73M
428.24%3.91M
-161.46%-3.74M
-48.51%1.25M
-898.26%-5.15M
72.42%8.73M
85.00%740K
-Change in other current assets
94.29%-2K
-83.33%1K
369.23%35K
99.59%-41K
-98.31%1K
99.65%-35K
50.00%6K
-425.00%-13K
-7,096.40%-10M
137.58%59K
-Change in other current liabilities
46.43%-210K
59.11%-608K
-823.08%-188K
-243.47%-2.44M
-249.87%-586K
-117.95%-392K
-233.41%-1.49M
106.06%26K
259.47%1.7M
207.71%391K
-Change in other working capital
-8.14%-11.61M
18.99%-7.78M
-12.23%-6.47M
-86.99%-31.53M
-23.12%-5.43M
-118.13%-10.73M
-154.52%-9.6M
-53.43%-5.77M
-40.01%-16.86M
-18.70%-4.41M
Cash from discontinued investing activities
Operating cash flow
-7.24%-33.39M
3.54%-23.61M
-8.45%-37.86M
-8.16%-117.98M
2.83%-27.47M
-58.76%-31.14M
22.40%-24.47M
-17.67%-34.91M
-83.24%-109.08M
-67.23%-28.27M
Investing cash flow
Cash flow from continuing investing activities
157.48%32.57M
-61.15%12.7M
-135.51%-11.2M
56.92%41.43M
368.56%33.85M
-472.10%-56.66M
-7.91%32.69M
369.28%31.55M
114.39%26.4M
72.12%-12.61M
Net PPE purchase and sale
-618.75%-115K
51.81%-320K
68.55%-195K
80.16%-1.53M
78.29%-226K
99.51%-16K
63.34%-664K
60.28%-620K
-318.73%-7.69M
-49.57%-1.04M
Net investment purchase and sale
157.70%32.69M
-60.96%13.02M
-134.22%-11.01M
25.99%42.95M
394.69%34.08M
-406.09%-56.65M
-10.60%33.35M
416.77%32.17M
118.77%34.09M
74.02%-11.56M
Cash from discontinued investing activities
Investing cash flow
157.48%32.57M
-61.15%12.7M
-135.51%-11.2M
56.92%41.43M
368.56%33.85M
-472.10%-56.66M
-7.91%32.69M
369.28%31.55M
114.39%26.4M
72.12%-12.61M
Financing cash flow
Cash flow from continuing financing activities
-97.01%2.4M
123.72%1.31M
58,779.45%42.98M
5,002.54%82.41M
178.37%1.47M
70,944.25%80.28M
-18.38%586K
-71.60%73K
-99.55%1.62M
539.17%527K
Net common stock issuance
--0
--0
--41.72M
--80.02M
--178K
--79.84M
--0
--0
--0
----
Proceeds from stock option exercised by employees
444.67%2.4M
123.72%1.31M
1,624.66%1.26M
19.59%1.94M
59.58%841K
290.27%441K
-18.38%586K
-72.45%73K
53.40%1.62M
421.78%527K
Net other financing activities
----
----
----
5,700.00%448K
----
----
----
----
99.95%-8K
--0
Cash from discontinued financing activities
Financing cash flow
-97.01%2.4M
123.72%1.31M
58,779.45%42.98M
5,002.54%82.41M
178.37%1.47M
70,944.25%80.28M
-18.38%586K
-71.60%73K
-99.55%1.62M
539.17%527K
Net cash flow
Beginning cash position
-22.08%54.13M
5.04%63.73M
9.15%69.81M
-55.90%63.96M
-40.60%61.96M
-36.01%69.48M
-41.60%60.68M
-55.90%63.96M
373.01%145.02M
-49.67%104.3M
Current changes in cash
121.04%1.58M
-209.06%-9.6M
-85.14%-6.08M
107.22%5.85M
119.46%7.85M
-76.09%-7.52M
88.32%8.8M
92.02%-3.28M
-170.88%-81.07M
35.17%-40.34M
End cash Position
-10.07%55.72M
-22.08%54.13M
5.04%63.73M
9.15%69.81M
9.15%69.81M
-40.60%61.96M
-36.01%69.48M
-41.60%60.68M
-55.90%63.96M
-55.90%63.96M
Free cash flow
-7.56%-33.51M
4.81%-23.93M
-7.11%-38.05M
-2.34%-119.51M
5.51%-27.69M
-36.09%-31.15M
24.62%-25.14M
-13.77%-35.53M
-90.29%-116.77M
-66.54%-29.31M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -7.24%-33.39M3.54%-23.61M-8.45%-37.86M-8.16%-117.98M2.83%-27.47M-58.76%-31.14M22.40%-24.47M-17.67%-34.91M-83.24%-109.08M-67.23%-28.27M
Net income from continuing operations -31.01%-29.17M-23.38%-25.55M-35.37%-37.91M5.95%-101.74M-5.86%-30.76M23.36%-22.26M16.69%-20.71M-11.11%-28.01M-85.76%-108.18M-31.82%-29.06M
Depreciation and amortization 1.47%622K4.64%632K7.57%625K50.19%2.42M8.25%617K47.00%613K93.59%604K88.03%581K79.26%1.61M122.66%570K
Other non cash items 0.86%941K7.56%968K3.86%915K107.20%3.63M361.62%914K14.90%933K176.07%900K112.29%881K32.35%1.75M-50.99%198K
Change In working capital 26.47%-11.78M37.03%-5.99M41.55%-6.83M-105.30%-37.97M81.15%-750K-446.46%-16.02M11.53%-9.51M-39.36%-11.69M-63.01%-18.49M-278.63%-3.98M
-Change in receivables --0--0--0--2M--0--0--0--2M--0--0
-Change in prepaid assets -10.63%-1.24M566.04%2.14M112.94%360K-8.22%-2.23M279.26%1.36M-109.87%-1.12M103.58%321K24.52%-2.78M34.92%-2.06M-1,301.59%-757K
-Change in payables and accrued expense 134.22%1.28M-79.61%254K88.99%-567K-142.79%-3.73M428.24%3.91M-161.46%-3.74M-48.51%1.25M-898.26%-5.15M72.42%8.73M85.00%740K
-Change in other current assets 94.29%-2K-83.33%1K369.23%35K99.59%-41K-98.31%1K99.65%-35K50.00%6K-425.00%-13K-7,096.40%-10M137.58%59K
-Change in other current liabilities 46.43%-210K59.11%-608K-823.08%-188K-243.47%-2.44M-249.87%-586K-117.95%-392K-233.41%-1.49M106.06%26K259.47%1.7M207.71%391K
-Change in other working capital -8.14%-11.61M18.99%-7.78M-12.23%-6.47M-86.99%-31.53M-23.12%-5.43M-118.13%-10.73M-154.52%-9.6M-53.43%-5.77M-40.01%-16.86M-18.70%-4.41M
Cash from discontinued investing activities
Operating cash flow -7.24%-33.39M3.54%-23.61M-8.45%-37.86M-8.16%-117.98M2.83%-27.47M-58.76%-31.14M22.40%-24.47M-17.67%-34.91M-83.24%-109.08M-67.23%-28.27M
Investing cash flow
Cash flow from continuing investing activities 157.48%32.57M-61.15%12.7M-135.51%-11.2M56.92%41.43M368.56%33.85M-472.10%-56.66M-7.91%32.69M369.28%31.55M114.39%26.4M72.12%-12.61M
Net PPE purchase and sale -618.75%-115K51.81%-320K68.55%-195K80.16%-1.53M78.29%-226K99.51%-16K63.34%-664K60.28%-620K-318.73%-7.69M-49.57%-1.04M
Net investment purchase and sale 157.70%32.69M-60.96%13.02M-134.22%-11.01M25.99%42.95M394.69%34.08M-406.09%-56.65M-10.60%33.35M416.77%32.17M118.77%34.09M74.02%-11.56M
Cash from discontinued investing activities
Investing cash flow 157.48%32.57M-61.15%12.7M-135.51%-11.2M56.92%41.43M368.56%33.85M-472.10%-56.66M-7.91%32.69M369.28%31.55M114.39%26.4M72.12%-12.61M
Financing cash flow
Cash flow from continuing financing activities -97.01%2.4M123.72%1.31M58,779.45%42.98M5,002.54%82.41M178.37%1.47M70,944.25%80.28M-18.38%586K-71.60%73K-99.55%1.62M539.17%527K
Net common stock issuance --0--0--41.72M--80.02M--178K--79.84M--0--0--0----
Proceeds from stock option exercised by employees 444.67%2.4M123.72%1.31M1,624.66%1.26M19.59%1.94M59.58%841K290.27%441K-18.38%586K-72.45%73K53.40%1.62M421.78%527K
Net other financing activities ------------5,700.00%448K----------------99.95%-8K--0
Cash from discontinued financing activities
Financing cash flow -97.01%2.4M123.72%1.31M58,779.45%42.98M5,002.54%82.41M178.37%1.47M70,944.25%80.28M-18.38%586K-71.60%73K-99.55%1.62M539.17%527K
Net cash flow
Beginning cash position -22.08%54.13M5.04%63.73M9.15%69.81M-55.90%63.96M-40.60%61.96M-36.01%69.48M-41.60%60.68M-55.90%63.96M373.01%145.02M-49.67%104.3M
Current changes in cash 121.04%1.58M-209.06%-9.6M-85.14%-6.08M107.22%5.85M119.46%7.85M-76.09%-7.52M88.32%8.8M92.02%-3.28M-170.88%-81.07M35.17%-40.34M
End cash Position -10.07%55.72M-22.08%54.13M5.04%63.73M9.15%69.81M9.15%69.81M-40.60%61.96M-36.01%69.48M-41.60%60.68M-55.90%63.96M-55.90%63.96M
Free cash flow -7.56%-33.51M4.81%-23.93M-7.11%-38.05M-2.34%-119.51M5.51%-27.69M-36.09%-31.15M24.62%-25.14M-13.77%-35.53M-90.29%-116.77M-66.54%-29.31M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data